Market Cap 1.69B
Revenue (ttm) 792.32M
Net Income (ttm) 16.39M
EPS (ttm) N/A
PE Ratio 36.75
Forward PE 24.84
Profit Margin 2.07%
Debt to Equity Ratio 0.68
Volume 1,314,200
Avg Vol 1,501,484
Day's Range N/A - N/A
Shares Out 383.61M
Stochastic %K 44%
Beta 1.25
Analysts Sell
Price Target $6.75

Latest News on GDRX

GoodRx Launches eCommerce Offering for Retail Pharmacies

Apr 3, 2025, 2:02 PM EDT - 6 hours ago

GoodRx Launches eCommerce Offering for Retail Pharmacies


GoodRx: Great Value For Patient Investors (Upgrade)

Mar 24, 2025, 4:16 PM EDT - 10 days ago

GoodRx: Great Value For Patient Investors (Upgrade)


GoodRx Holdings, Inc. (GDRX) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 11:37 AM EST - 5 weeks ago

GoodRx Holdings, Inc. (GDRX) Q4 2024 Earnings Call Transcript


GoodRx Reports Fourth Quarter and Full Year 2024 Results

Feb 27, 2025, 6:05 AM EST - 5 weeks ago

GoodRx Reports Fourth Quarter and Full Year 2024 Results


Scott Wagner Joins GoodRx Board of Directors

Jan 22, 2025, 5:00 PM EST - 2 months ago

Scott Wagner Joins GoodRx Board of Directors


GoodRx CFO Karsten Voermann to Resign for Personal Reasons

Jan 13, 2025, 6:00 PM EST - 2 months ago

GoodRx CFO Karsten Voermann to Resign for Personal Reasons


GoodRx Holdings, Inc. (GDRX) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 2:14 PM EST - 5 months ago

GoodRx Holdings, Inc. (GDRX) Q3 2024 Earnings Call Transcript


GoodRx Reports Third Quarter 2024 Results

Nov 7, 2024, 6:05 AM EST - 5 months ago

GoodRx Reports Third Quarter 2024 Results


GoodRx and CVS Sued for Suppressing Pharmacy Reimbursement

Nov 5, 2024, 3:44 PM EST - 5 months ago

GoodRx and CVS Sued for Suppressing Pharmacy Reimbursement

CVS


GoodRx to Participate in Upcoming Investor Conferences

Nov 4, 2024, 4:05 PM EST - 5 months ago

GoodRx to Participate in Upcoming Investor Conferences


GoodRx Unveils New E-commerce Platform, Launches with Opill®

Oct 31, 2024, 9:00 AM EDT - 5 months ago

GoodRx Unveils New E-commerce Platform, Launches with Opill®


Ronald E. Bruehlman Joins GoodRx Board of Directors

Oct 28, 2024, 8:00 AM EDT - 5 months ago

Ronald E. Bruehlman Joins GoodRx Board of Directors


GoodRx Holdings: Failing To Gain Much Traction

Oct 8, 2024, 2:46 PM EDT - 6 months ago

GoodRx Holdings: Failing To Gain Much Traction


GoodRx Holdings, Inc. (GDRX) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 1:07 PM EDT - 8 months ago

GoodRx Holdings, Inc. (GDRX) Q2 2024 Earnings Call Transcript


GoodRx Reports Second Quarter 2024 Results

Aug 8, 2024, 6:05 AM EDT - 8 months ago

GoodRx Reports Second Quarter 2024 Results


GoodRx Q2 Earnings Preview

Jul 31, 2024, 3:44 AM EDT - 8 months ago

GoodRx Q2 Earnings Preview


Boehringer-GoodRx partner to offer Humira rival at 92% discount

Jul 18, 2024, 10:46 AM EDT - 9 months ago

Boehringer-GoodRx partner to offer Humira rival at 92% discount


Ian T. Clark Joins GoodRx Board of Directors

Jul 10, 2024, 9:00 AM EDT - 9 months ago

Ian T. Clark Joins GoodRx Board of Directors


GoodRx Debuts Tracker to Monitor Out-of-Pocket Prescription Costs

Jun 26, 2024, 4:57 PM EDT - 10 months ago

GoodRx Debuts Tracker to Monitor Out-of-Pocket Prescription Costs